Research graph
References from Case Report: Prolonged thrombocytopenia after chemotherapy in solid tumors requiring long-term thrombopoietin receptor agonist support: a five-patient case series. Local targets link to admitted publications; unresolved targets remain external evidence.
Chemotherapy-induced thrombocytopenia: modern diagnosis and treatment
10.1111/bjh.20037 · 2025 · External reference
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic Malignancies
10.1111/ejh.13595 · 2021 · External reference
Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy
10.1016/j.jtha.2023.09.031 · 2024 · External reference
Unresolved reference
External reference
Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007
10.1016/j.clinthera.2009.11.020 · 2009 · External reference
Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic Malignancies
10.3324/haematol.2021.279512 · 2022 · External reference
Managing thrombocytopenia associated with cancer chemotherapy
2015 · External reference
Romiplostim treatment of chemotherapy-induced thrombocytopenia
10.1200/jco.18.01931 · 2019 · External reference
Romiplostim versus placebo for chemotherapy-induced thrombocytopenia
10.1056/nejmoa2511882 · 2026 · External reference
The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials
10.3389/fphar.2025.1683857 · 2025 · External reference
Avatrombopag versus placebo for persistent chemotherapy-induced thrombocytopenia in GI cancers: the phase II ACT-GI trial
10.1200/jco-26-00568 · 2026 · External reference
Eltrombopag for chemotherapy-induced thrombocytopenia: A multicenter retrospective real-world study
10.3390/hematolrep18030039 · 2026 · External reference
Avatrombopag switching from other thrombopoietic agents in severe and persistent cancer treatment-induced thrombocytopenia: a multicentre real-world study. Original Research
10.3389/fmed.2026.1898479 · 2026 · External reference
Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA
10.1182/bloodadvances.2024015635 · 2025 · External reference
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
10.1111/bjh.18081 · 2022 · External reference
Acquired amegakaryocytic thrombocytopenic purpura: A review of therapeutic options
10.56875/2589-0646.1063 · 2023 · External reference
Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor
10.1158/0008-5472.can-06-4303 · 2007 · External reference
Chemo/radiotherapy-induced bone marrow niche alterations
10.1080/07357907.2020.1855353 · 2021 · External reference
Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy
10.1016/0360-3016(94)00430-s · 1995 · External reference
Chemotherapy-induced thrombocytopenia: literature review
10.1007/s12672-023-00616-3 · 2023 · External reference
